Subscribe to Search results

Within a memo to Dr Doyle, Dr Rejman wrote that he would agree that Dr Pickles that some fundholders might well not be happy about paying for haemophilia patients, some of whom may cost £250,000 per annum on a recurring basis.

Published on:

Randolph Peter Gordon-Smith contracted Hepatitis C, which later developed into hepatocellular cancer. His daughters cared for him after chemotherapy.

Published on:

Randolph Peter Gordon-Smith discussed alternative treatment options with his oncologist.

Published on:

Randolph Peter Gordon-Smith discussed the role of the community palliative care team with his oncologist.

Published on:

Julia Gordon-Smith's sisters arranged a team of carers for their father. Julia reflected that sufferers of contaminated blood should have been taken care of properly before it was too late.

Published on:

Robert Finch sent an email to Zubeda Seedat regarding the issue surrounding Lord Owen's missing papers.

Published on:

Professor Cash had alleged that documents had been destroyed.

Published on:

The 1971 "Guide for Departmental Records Officers" set out guidance for document retention and management by departmental records officers.

Published on:

A branch reviewing officer would decide whether to mark a file for second review or whether it could be destroyed at an appropriate date between 2 and 15 years after the last action on the file.

Published on:

In his written evidence to the Inquiry, Brendan Sheehy (a departmental records officer in the Department of Health and Social Care) stated that "the departmental policy was not to store the papers that had been seen by Lord Owen personally or his personal responses as a complete set, but rather to keep complete 'policy' files."

Published on:

The Shepherd Review led to the DRO working with private office staff in the Department of Health to set up a registered filing system.

Published on:

During the BSE Inquiry, a number of former ministers who gave evidence were critical about the fact that documents they had reviewed and written on had not been preserved.

Published on:

When the Department of Health had to give evidence to the BSE Inquiry they realised that there had been shortcomings in their system of handling private office papers. They took some action in response.

Published on:

Professor John Dillon stated in his written statement that "All patients in Scotland have access to treatment with a direct acting antiviral regimen, irrespective of stage of disease or route of infection" and that no waiting lists for treatment exist in Scotland.

Published on:

In his written evidence, Dr Stephen Barclay noted that almost 90% of those infected with Hepatitis C in Scotland been identified and the majority of those had received treatment.

Published on:

In response to Professor Makris' concerns regarding patients who may have undergone Hepatitis C treatment solely directed by haemophilia centres, Dr Stephen Barclay stated that he had confirmed this practice did not take place in Scotland.

Published on:

Professor Chris Jones, DCMO, told the Inquiry: "The Welsh Government allocated additional resources to health boards for the new antiviral medications in 2015/16. Funding was allocated in line with anticipated health board treatment demand and there was no cap put on the number of patients that could be treated within any health board."

Published on:

Professor Chris Jones stated in his written evidence that in Wales there are currently no restrictions on treatment for Hepatitis C and currently no waiting lists for treatment.

Published on:

Monitoring of patients in Wales is dependent on the nature of the damage done by Hepatitis C prior to treatment. Professor Jones explained that patients are discharged if there is minimal liver damage, whereas those with advanced liver disease will be monitored by a hepatology clinic, including having regular scans.

Published on:

In his statement, Professor Chris Jones stated that an oversight group had been set up by the Welsh Government to oversee the elimination of Hepatitis across the 7 Welsh health boards through public awareness and improved access to testing.

Published on: